Covid19
Showing NaN - NaN of 19
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury Trial in United States (Cannabis, Medical, RYAH-Medtech Inhaler)
Recruiting
- Chronic Pain
- +32 more
- Cannabis, Medical
- RYAH-Medtech Inhaler
-
Boca Raton, Florida
- +16 more
May 29, 2022
Covid19 Trial in Gainesville (Silmitasertib, SOC)
Completed
- Covid19
-
Gainesville, GeorgiaCenter for Advanced Research and Education
May 5, 2022
Swallowing Impairment After COVID-19 Infection
Completed
- Covid19
- Videofluoroscopic Swallowing Study (VFSS)
-
Gainesville, Florida
- +1 more
Apr 1, 2022
Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))
Active, not recruiting
- Covid19
- Sotrovimab (Gen1)
- Sotrovimab (Gen2)
-
Anniston, Alabama
- +30 more
Feb 4, 2022